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Abstract
Objective: To study the postnatal growth and short-term complications in very low birth weight preterm neonates receiving total 
parenteral nutrition (TPN). Methods: This prospective, observational study was conducted in the neonatal intensive care unit of 
a tertiary care hospital in South India. All neonates with birth weight <1250 g and <32 weeks of gestation who received TPN 
and survived at least 7 days were studied prospectively. Amino acid infusion was started at 1 g/kg/day on day 1 and graded up to 
4 g/kg/day. Lipids were started on the day 2 of life at 1 g/kg/day and graded up to 3 g/kg/day. Enteral feeds were introduced within 
3 days of life. TPN was stopped once enteral feeds reached 100 ml/kg/day. Postnatal growth and biochemical and hematological 
parameters were also monitored. Results: Time to reach full enteral feeds was 11.3±4.5 days, cumulative weight loss proportion 
(in %) was 8.5±4.7, and number of days to regain birth weight was 11.1±4.5 days. Mean growth velocity (GV) at 30 days of life 
and 40 weeks of postmenstrual age (PMA) was 16.37±4.8 g/kg/day and 20.03±5.8 g/day, respectively. Mean GV of appropriate 
for gestational age (AGA) infants was 3.13 g/kg/day, lower compared to small for GA (SGA) infants at 30 days PMA (p=0.01). 
However, there was no statistical difference in GV between AGA and SGA infants at 40 weeks of PMA. There was no correlation 
between energy intake on the day 7 and weight and head circumference at 40 weeks of PMA. Hyponatremia was observed in 40.6% 
infants receiving TPN, and there were no other significant complications. Conclusion: Conventional TPN was associated with 
favorable postnatal growth until 30 days of postnatal life. However, catch-up growth at 40 weeks of PMA was not satisfactory. Mean 
GV of AGA infants was found to be lower compared to that in SGA infants at 30 days of postnatal life. Besides hyponatremia, there 
was no major complication due to TPN in this study.
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Very low birth weight (VLBW) infants are born at a time of otherwise rapid intra-uterine brain and body growth. These infants have very limited endogenous stores and 
increased metabolic demands; hence, the rapid establishment 
of postnatal nutrition is essential. The goal should be to provide 
nutrition to achieve a growth velocity (GV) similar to intra-
uterine GV. Parenteral nutrition must be initiated as soon as 
possible in VLBW preterm infants to prevent postnatal growth 
failure and improve neurodevelopmental outcome [1]. The 
Committee on Nutrition of the American Academy of Pediatrics 
has recommended a caloric intake of 120 Kcal/kg/day for 
children enterally fed and 80-100 Kcal/kg/day for those 
receiving total parenteral nutrition (TPN), with a protein intake 
of 3.5-4 g/kg/day [2].
However, it is difficult for the most VLBW infants to reach 
the suggested caloric and protein intake in the first few weeks 
of life due to need for fluid restriction, delayed initiation of 
parenteral aminoacid solutions and lipids, and immaturity of 
intestinal functions, all of which contribute to the slow process 
of enteral and parenteral nutrition. Most infants gain less weight 
compared to fetuses of the same gestational age (GA). As a 
result of this growth deficit, a large proportion of such infants 
remain below the 10th centile for postmenstrual age (PMA), 
and this subnormal growth often persists into childhood with 
potential adverse effects on later neurodevelopment [3]. 
Greater weight gain before 40 weeks PMA is associated with 
better outcomes [3].
Thus, it remains important to understand the nutritional 
factors that influence growth in the early neonatal period and to 
identify factors that might maximize the growth. Conventional 
TPN is being used in almost all tertiary care neonatal intensive 
care units (NICUs) for preterm neonates, but there are few 
studies which examined the impact of conventional TPN on the 
early growth pattern of these neonates. Hence in this study, we 
examined the impact of nutritional practices on GV during the 
first month of life and at 40 weeks of PMA.
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METHODS
This observational study was conducted prospectively from 
January 2012 to August 2013 at NICU of a tertiary center in 
South India. We obtained approval of Institutional Ethics 
Committee for this study and parents’ consent was taken before 
enrollment of subjects. Both inborn and outborn neonates with 
birth weight <1250 g and <32 weeks of gestation who received 
TPN and survived at least 7 days were included. Neonates with 
major congenital anomalies, syndromic features, referred after 
day 3 of life, critically ill and hence could not be disconnected 
from the ventilator for interventions like weighing were 
excluded from the study.
The neonates satisfying the inclusion criteria were started on 
intravenous (IV) Fluids and considered for TPN administration 
from day 1 of life. This practice was based on the guidelines 
that all premature neonates <35 weeks of gestation should be 
started on parenteral nutrition along with enteral nutrition [4]. 
The total fluid of 80 ml/kg/day were administered on the day 1 of 
life and increased daily by 20 ml/kg/day up until 150 ml/kg/day 
was reached. Dextrose with calcium was given on first 2 days 
of life, and electrolytes were added from the day 3 onward. 
Dextrose was started at glucose infusion rate of 6 mg/kg/min 
on day 1 of life and increased or decreased so that a glucometer 
random blood glucose levels were maintained between 60 and 
120 mg/dl. Sodium was supplemented at 3-5 mEq/kg/day and 
potassium at 2 mEq/kg/day and titrated according to serum 
electrolyte levels which were done twice a week.
Parenteral nutrition included amino acids (10% aminoven) 
and lipids (10% intralipids), which were started at 1 g/kg/d and 
both were graded up every day by 1 g/kg/day up to maximum 
of 4 g/kg/day for amino acids and 3 g/kg/d for lipids. Parenteral 
nutrient admixtures were prepared under laminar flow. Amino 
acids and lipids were infused separately, and lipid was covered 
with dark paper if neonate was receiving phototherapy. The 
bottles along with tubings were changed every 24 h.
Biochemical and hematological parameters were monitored 
as the TPN was graded up. Serum electrolytes and renal 
function tests were done twice a week (on day 4, 7, 11…). 
Blood gas analysis was done on the day 4. Liver function tests 
(LFT), total cholesterol, triglyceride (TG), and complete blood 
counts were done weekly once. Lipid solution was decreased 
by 0.5 g/kg/day when TG was between 170 and 200 mg/dL. 
Intralipid was stopped when the liver enzymes were elevated 
more than three times normal limits and TG above 200 mg/dL. 
The amino acid administration was stopped when the serum 
creatinine was more than 95th centile for the GA.
Expressed breast milk was introduced within 3 days of life. 
If breast milk was not available, enteral nutrition was delayed. 
Feeds were graded up by 10-20 ml/kg/day as tolerated by 
the neonates. Feeds were interrupted when there was blood 
tinged or coffee ground aspirate, abdominal girth measured at 
the umbilicus increased by 2 cm or more from baseline in 6 h 
interval, reduced/absent bowel sounds, abdominal tenderness, 
and gastric residual volume was 50% or more. TPN was 
stopped once enteral feeds reached 100 ml/kg/day.
GA was estimated by antenatal ultrasonogram or last 
menstrual period. Detailed nutritional data included type and 
volume of IV solutions, the composition of parenteral nutrition, 
type, and volume of enteral feedings and additives. All infants 
were weighed unclothed using Essae DS 252 weighing scale 
which has an accuracy of 5 g. Weight was recorded daily until 
discharge and at 40 weeks of PMA. Because of the expected 
weight loss during the first 10 days of life, GV was calculated for 
the interval between days 10 and 30 by the following formula:
GV at 30 days in g/kg/day = 1000×([wt 30−wt 10]/wt 10)/
(30-10). GV at 40 weeks of PMA in g/day = wt at 40 weeks 
PMA - wt at day 10/number of days between 40 weeks of 
PMA and day 10. Head circumference (HC) was recorded after 
24 h of life and at 40 weeks PMA. Growth was plotted on the 
Fenton’s fetal-infant growth chart which mimics intra-uterine 
growth curves. Neonatal morbidity, mortality, and laboratory 
details were recorded in the study proforma. Neonatal 
morbidity included sepsis (clinical and culture proven), intra-
ventricular hemorrhage (IVH), patent ductus arteriosus (PDA), 
periventricular leukomalacia (PVL), retinopathy of prematurity 
(ROP), and bronchopulmonary dysplasia (BPD).
Neurosonogram was obtained on the day 3 and day 30 of 
life to look for IVH and PVL, respectively. Echocardiography 
was done at the end of the first week to rule out PDA or other 
cardiac anomalies. Screening for ROP was done at 32 weeks or 
at postnatal age of 4 weeks whichever was later.
Data were analyzed using SPSS Version 16.0 Software. 
Categorical variables were analyzed by chi-square test. p<0.05 
was considered as significant.
RESULTS
Study flow diagram:
The study population included 69 preterm (<32 weeks gestation) 
neonates. Among them, 21 were <28 weeks, 40 between 28 and 
30 weeks and 8 were >30 weeks. Neonates with birth weight 
<1000 g were 24 and 1000-1250 g were 45. 40 neonates were 
appropriate for GA (AGA), and 29 were small GA (SGA). The 
baseline nutrition and postnatal weight changes are provided 
in Table 1.
The mean GV of AGA neonates was less compared to SGA 
neonates by 3.13 g/kg/d at 30 days of postnatal life, with a GV 
of 15.04±4.32 g/kg/d for AGA and 18.17±5.02 g/kg/d for SGA 
neonates. This difference was statistically significant (p=0.01). 
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However, there was no significant difference in GV between 
SGA (19.7±6.1) and AGA (20.27±5.75) infants at 40 weeks of 
PMA.
Weight of seven neonates was above 10th centile at 40 weeks 
of PMA, and 21 babies had HC above 10th centile at 40 weeks 
of PMA. 45% infants were SGA at birth, and at 40 weeks PMA, 
76% remained below 3rd centile for weight (of the intra-uterine 
curves). However, 76% infants had HC >3rd centile (Tables 2 
and 3). There was no correlation between energy intake on the 
day 7 and weight and HC at 40 weeks of PMA.
Clinical sepsis was present in 24.6% of cases while culture 
positive sepsis was seen in 18.8% cases. Out of the 13 babies 
with culture-proven sepsis, seven had growth of Klebsiella, 
three had Staphylococcus aureus, one had Enterococcus, 
and two had Enterobacter. Sepsis was most common among 
the neonates with 29-32 weeks of gestation which also had 
a central line inserted for TPN. Other complications include 
PDA (18.8%), ROP (24.5%), IVH (2.9%), and PVL (1.5%). 
9 (13.04%) neonates expired before discharge, out of which 8 
neonates expired in the late neonatal period, and 1 expired after 
the neonatal period.
The overall incidence of dyselectrolytemia was 71% with 
hyponatremia being the most common abnormality (40.6% 
cases), followed by hypernatremia in 7.2% and hyperkalemia in 
1.4% neonates. 13 neonates had sodium levels between 125 and 
129 mEq/L, 9 had levels between 120 and 124 mEq/L, and 6 
had sodium <120 mEq/L. Two had apnea due to hyponatremia, 
and none suffered from seizures. Out of 13 neonates, who had 
metabolic acidosis, five had clinical sepsis, five had culture-
proven sepsis, and three had necrotizing enterocolitis. Urea was 
elevated in 18.8% neonates receiving TPN; however, only one 
neonate (1.4%) developed acute kidney injury.
Samples for LFT could not be collected at the right time for all 
infants. Results of liver enzymes were available for 55 neonates, 
total protein and albumin for 53 neonates, and cholesterol and 
TGs for 52 neonates. 15.4% neonates had elevated TGs while 
17.3% had hypercholesterolemia and elevated liver enzymes 
in none of the neonates. Hypoalbuminemia with normal total 
protein content was seen in 4 (7.5%) neonates, out of which 
three also had culture-proven sepsis. 28.9% neonates developed 
thrombocytopenia after starting TPN or had decreasing platelet 
count from that at birth. Among that, 18.8% had sepsis as a 
confounding factor.
DISCUSSION
The postnatal weight loss (%), age at which birth weight 
regained and subsequent weight gain in the present study were 
similar to the reports by Paul et al., [5] (1991-1997), Wright 
et al., [6] (1987-1991), and Ehrenkranz et al. [7] (1994-1995). 
The studies conducted on preterm receiving TPN after the year 
1990 show better growth pattern probably due to the improved 
Number of neonates <1250 g/ 
<32weeks admitted in NICU was 
104
83 inborn and 21 outborn
69 included in the final analysis
58 infants were followed up to 40 weeks PMA 
     (8 expired during late neonatal period 
     1 in post neonatal period 
     2 lost for follow up)
35 excluded
20 expired within 7 days of life,  
3 congenital anomalies and 1 syndromic, 
5 received no TPN, 
1 had birth asphyxia, 
4 critically ill
1 referred after day 3
Three congenital anomalies were one jejunal atresia, one with left renal agenesis, grade 4 VUR
  on right side and hydronephrosis and another with chondrodysplasia punctata.
1 syndrome was 46 XY, penoscrotal hypospadiasis with pulmonary artery stenosis (46 XY – 15 PS +)
Table 1: Nutrition and postnatal weight changes
Variables Mean±SD Median Range
Age at which enteral 
feeds started (in days)
2.5±1.5 3 1-11
Time to reach full enteral 
feeds (in days)
11.3±4.5 10 5-26
Calorie intake on D7 92.6±13.1 94 62-134
Cumulative wt loss 
proportion (%)
8.5±4.7 9.0 0-21
Number of days to regain 
birth weight (in days)
11.1±4.5 11 0-26
Table 2: Correlation between energy intake on day 7 and 
weight at 40 weeks PMA
Weight 
centile
Calorie intake on day 7 p value
<100 Kcals/kg/d >100 Kcals/kg/d
n=38 % n=20 %
<3rd 31 81.6 13 65 0.15
3rd-10th 4 10.5 3 15
10th-50th 3 7.9 4 20
Table 3: Correlation between energy intake on day 7 and 
head growth at 40 weeks PMA
HC 
centile
Calorie intake on day 7 p value
<100 Kcals/kg/d >100 Kcals/kg/d
n=38 % n=20 %
<3rd 11 28.9 3 15 0.72
3rd-10th 14 36.8 9 45
10th-50th 12 31.6 7 35
50th-90th 1 2.6 1 5
HC: Head circumference
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nutritional practices in the last two decades. In the present 
study, mean GV of AGA infants was less compared to that 
of SGA infants by 3.13 g/kg/day at 30 days of postnatal life. 
Similar findings were reported earlier by Paul et al. [5] where 
mean GV of AGA infants was less compared to SGA infants by 
3.6 g/kg/day at 30 days of life.
Embleton et al. [8] showed poor weight gain in the postnatal 
period related to increasing cumulative energy and protein 
deficits with maximum deficits occurring during the first week 
of postnatal life. In this study, we compared energy intake 
on the day 7 (<100/kcal/kg/day and >100 Kcal/kg/day) with 
weight and HC at 40 weeks PMA which was statistically not 
significant.
Among the study neonates, we observed clinical sepsis 
more often than culture positive sepsis. Culture positive sepsis 
included mostly Gram-negative sepsis. Beganovic et al. [9] 
reported clinical sepsis in 38.0% and culture positive sepsis 
in 10.8% among preterm infants receiving TPN. The most 
common cause for sepsis was Staphylococcus epidermidis 
followed by S. aureus. In the study by Beganovic et al., GA 
was included in logistic regression analysis, but the odds ratio 
was still high for TPN and sepsis [9].
We provided TPN to <1250 g birth weight neonates in 
whom the prevalence of PDA is usually high. The incidence 
of PDA in this population varies between 18 and 77% [10-12]. 
We did not find any relationship between TPN and PDA in our 
study. In contrast, in a study by Lee et al. [13] delayed closure 
of PDA was correlated positively with increased ventilation 
support, hospitalization, time to full enteral feeds, and duration 
of TPN.
Poor postnatal weight gain is a predictor of severe ROP. 
One study reported that infusion of lipids >2 g/kg/day during 
first 7 days of life was associated with decreased rates of 
ROP [14]. The authors concluded that the risk of developing 
severe ROP in extremely premature infants might be reduced by 
improving nutritional support, specifically targeting lipids and 
total calories, and thereby improving weight gain. There was 
no relationship of ROP, IVH, and PVL to TPN administration 
in the present study.
The incidences of hyponatremia, hypernatremia, and 
hyperkalemia in our study were lower compared to reported 
incidences of corresponding electrolyte abnormalities of 
61.4%, 23.4%, and 30.3%, respectively, in a study by Jacob 
et al. [15]. Jacob et al. studied electrolyte abnormalities by 
multiple measurements and adjusted the fluid and electrolyte 
infusion once or twice daily. They also reported raised BUN 
and creatinine in 16.6% of neonates receiving TPN with the 
mean onset age of 15.6±12.6 days. Only one neonate developed 
acute kidney injury in the present study. Elevated TG level was 
observed in lesser percentages of neonates receiving TPN in the 
present study compared to 62% in a trial carried out by Martin 
et al. [16]
Our study had few limitations such as small sample size and 
not enrolling the controls.
CONCLUSION
Conventional TPN mimics intra-uterine growth until 30 days of 
postnatal life. However, catch-up growth at 40 weeks of PMA 
was not satisfactory which indicate that growth at 40 weeks of 
PMA depends on other factors besides TPN. Mean GV of AGA 
infants was found to be lower compared to that in SGA infants 
at 30 days of postnatal life. Besides hyponatremia, there was no 
major complication due to TPN in this study.
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